SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Claris Lifesciences receives ANDA approvals for Ondensetron Injection in US

25 Feb 2013 Evaluate

Claris Lifesciences (Claris) has received two abbreviated new drug application (ANDA) approvals for Ondensetron Injection in the United States of America (US). Ondansetron Injection is indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin and for prevention of postoperative nausea and/or vomiting.

The company plans to launch Ondensetron in two variants of 2 mg/ml in 2 ml single dosage vials and 20 ml multi dosage vials. The total addressable market size of the product is estimated at $49 million in the US.

Claris Lifesciences has recently received the long awaited USFDA approval for its manufacturing facility. The company now has nine ANDAs approved in its name across four molecules. The company has a total filing of 30 ANDAs across 20 products.

Peers
Company Name CMP
Redington 226.00
Adani Enterprises 2257.00
Amrapali Industries 17.30
Rashi Peripheral 476.95
PDS 290.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×